1 |
Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, et al. : Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol 251 : 47-52, 2004
DOI
|
2 |
Das A, Puvanendran K : A retrospective review of patients with clinically definite multiple sclerosis. Ann Acad Med Singapore 27 : 204-209, 1998
|
3 |
de Seze J, Blanc F, Jeanjean L, Zephir H, Labauge P, Bouyon M, et al. : Optical coherence tomography in neuromyelitis optica. Arch Neurol 65 : 920-923, 2008
|
4 |
Downer JJ, Leite MI, Carter R, Palace J, Kuker W, Quaghebeur G : Diagnosis of neuromyelitis optica (NMO) spectrum disorders : is MRI obsolete? Neuroradiology 54 : 279-285, 2012
DOI
|
5 |
Hui AC, Wong RS, Ma R, Kay R : Recurrent optic neuromyelitis with multiple endocrinopathies and autoimmune disorders. J Neurol 249 : 784-785, 2002
DOI
|
6 |
Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, et al. : Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131 (Pt 11) : 3072-3080, 2008
DOI
|
7 |
Kira J : Multiple sclerosis in the Japanese population. Lancet Neurol 2 : 117-127, 2003
DOI
|
8 |
Krampla W, Aboul-Enein F, Jecel J, Lang W, Fertl E, Hruby W, et al. : Spinal cord lesions in patients with neuromyelitis optica : a retrospective long-term MRI follow-up study. Eur Radiol 19 : 2535-2543, 2009
DOI
|
9 |
Mandler RN, Ahmed W, Dencoff JE : Devic's neuromyelitis optica : a prospective study of seven patients treated with prednisone and azathioprine. Neurology 51 : 1219-1220, 1998
DOI
|
10 |
Kuroiwa Y, Igata A, Itahara K, Koshijima S, Tsubaki T : Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases. Neurology 25 : 845-851, 1975
DOI
|
11 |
Lee M, Epstein FJ, Rezai AR, Zagzag D : Nonneoplastic intramedullary spinal cord lesions mimicking tumors. Neurosurgery 43 : 788-794; discussion 794-795, 1998
DOI
|
12 |
Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. : A serum autoantibody marker of neuromyelitis optica : distinction from multiple sclerosis. Lancet 364 : 2106-2112, 2004
DOI
|
13 |
Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, et al. : NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70 : 2197-2200, 2008
DOI
|
14 |
Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, et al. : Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 72 : 1077-1082, 2009
DOI
|
15 |
Nakamura M, Miyazawa I, Fujihara K, Nakashima I, Misu T, Watanabe S, et al. : Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study. J Neurol 255 : 163-170, 2008
DOI
|
16 |
Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N, et al. : A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology 72 : 1960-1961, 2009
DOI
|
17 |
Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto B, Graus F, et al. : Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. J Neurol 254 : 1233-1237, 2007
DOI
|
18 |
Schwartz TH, McCormick PC : Non-neoplastic intramedullary pathology. Diagnostic dilemma : to Bx or not to Bx. J Neurooncol 47 : 283-292, 2000
DOI
|
19 |
O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, et al. : Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 60 : 382-387, 1996
DOI
|
20 |
Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA : Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63 : 964-968, 2006
DOI
|
21 |
Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, et al. : EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 17 : 1019-3102, 2010
DOI
|
22 |
Sellner J, Lüthi N, Bühler R, Gebhardt A, Findling O, Greeve I, et al. : Acute partial transverse myelitis : risk factors for conversion to multiple sclerosis. Eur J Neurol 15 : 398-405, 2008
DOI
|
23 |
Vernant JC, Cabre P, Smadja D, Merle H, Caubarrere I, Mikol J, et al. : Recurrent optic neuromyelitis with endocrinopathies : a new syndrome. Neurology 48 : 58-64, 1997
DOI
|
24 |
Watanabe S, Misu T, Miyazawa I, Nakashima I, Shiga Y, Fujihara K, et al. : Low-dose corticosteroids reduce relapses in neuromyelitis optica : a retrospective analysis. Mult Scler 13 : 968-974, 2007
DOI
|
25 |
Watanabe S, Nakashima I, Misu T, Miyazawa I, Shiga Y, Fujihara K, et al. : Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 13 : 128-132, 2007
DOI
|
26 |
Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG : The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53 : 1107-1114, 1999
DOI
|
27 |
Wingerchuk DM, Weinshenker BG : Neuromyelitis optica : clinical predictors of a relapsing course and survival. Neurology 60 : 848-853, 2003
DOI
|
28 |
Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG : Revised diagnostic criteria for neuromyelitis optica. Neurology 66 : 1485-1489, 2006
DOI
|